The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction
Open accessAbstract
CTLA-4 (CD152) is a cell surface receptor that behaves as a negative regulator of the proliferation and the effector function of T cells. We have previously shown that CTLA-4 is also expressed on neoplastic lymphoid and myeloid cells, and it can be targeted to induce apoptosis. In our study, we have extended our analysis and have discovered that surface expression of CTLA-4 is detectable by flow cytometry on 30 of 34 (88%) cell lines derived from a variety of human malignant solid tumors including carcinoma, melanoma, neuroblastoma, rhabdomyosarcoma and osteosarcoma (but not in primary osteoblast-like cultures). However, by reverse transcriptase-PCR, CTLA-4 expression was detected in all cell lines. We have also found, by immunohistochemistry, cytoplasmic and surface expression of CTLA-4 in the tumor cells of all 6 osteosarcoma specimens examined and in the tumour cells of all 5 cases (but only weakly or no positivity at all in neighbouring nontumor cells) of ductal breast carcinomas. Treatment of cells from CTLA-4-expressing tumor lines with recombinant forms of the CTLA-4-ligands CD80 and CD86 induced apoptosis associated with sequential activation of caspase-8 and caspase-3. The level of apoptosis was reduced by soluble CTLA-4 and by anti-CTLA-4 scFvs antibodies. The novel finding that CTLA-4 molecule is expressed and functional on human tumor cells opens up the possibility of antitumor therapeutic intervention based on targeting this molecule.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Leach, D. R., Krummel, M. F., & Allison, J. P. (1996) · Science · doi:10.1126/science.271.5256.1734 · Cited by 3,955
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1208 · Cited by 1,604
Liyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Chambers, C. A., Kuhns, M. S., Egen, J. G., & Allison, J. P. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.565 · Cited by 998
Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers
Friedenstein, A. J., Chailakhyan, R. K., & Gerasimov, U. V. (1987) · Cell Proliferation · doi:10.1111/j.1365-2184.1987.tb01309.x · Cited by 983
Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A., & Peach, R. (1994) · Immunity · doi:10.1016/s1074-7613(94)80021-9 · Cited by 980
Krummel, M. F., & Allison, J. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2533 · Cited by 932
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
Garrido, F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M., & Stern, P. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(96)10075-x · Cited by 770
Intracellular Trafficking of CTLA-4 and Focal Localization Towards Sites of TCR Engagement
Linsley, P. S., Bradshaw, J., Greene, J., Peach, R., Bennett, K. L., & Mittler, R. S. (1996) · Immunity · doi:10.1016/s1074-7613(00)80480-x · Cited by 609
Levings, M. K., Sangregorio, R., Sartirana, C., Moschin, A. L., Battaglia, M., Orban, P. C., & Roncarolo, M.-G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021139 · Cited by 429
Isolation and characterization of osteoblast precursor cells from human bone marrow
Rickard, D. J., Kassem, M., Hefferan, T. E., Sarkar, G., Spelsberg, T. C., & Riggs, B. L. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110305 · Cited by 396
CTLA4 mediates antigen-specific apoptosis of human T cells.
Gribben, J. G., Freeman, G. J., Boussiotis, V. A., Rennert, P., Jellis, C. L., Greenfield, E., Barber, M., Restivo, V. A., Ke, X., & Gray, G. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.811 · Cited by 317
T cell anergy and costimulation
Appleman, L. J., & Boussiotis, V. A. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00009.x · Cited by 305
Dariavach, P., Mattéi, M., Golstein, P., & Lefranc, M. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181206 · Cited by 301
Magistrelli, G., Jeannin, P., Herbault, N., Benoit de Coignac, A., Gauchat, J.-F., Bonnefoy, J.-Y., & Delneste, Y. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3596::aid-immu3596>3.0.co;2-y · Cited by 276
Structural Analysis of CTLA-4 Function In Vivo
Masteller, E. L., Chuang, E., Mullen, A. C., Reiner, S. L., & Thompson, C. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5319 · Cited by 252
The death effector domain protein family: regulators of cellular homeostasis
Tibbetts, M. D., Zheng, L., & Lenardo, M. J. (2003) · Nature Immunology · doi:10.1038/ni0503-404 · Cited by 218
Seo, N., Hayakawa, S., Takigawa, M., & Tokura, Y. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01279.x · Cited by 206
Cassiede, P., Dennis, J. E., Ma, F., & Caplan, A. I. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110911 · Cited by 167
Schneider, H., Martín, M., Agarraberes, F. A., Yin, L., Rapoport, I., Kirchhausen, T. L., & Rudd, C. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.1868 · Cited by 152
Freeman, G. J., Lombard, D. B., Gimmi, C. D., Brod, S. A., Lee, K., Laning, J. C., Hafler, D. A., Dorf, M. E., Gray, G. S., & Reiser, H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.12.3795 · Cited by 150
Matulonis, U. A., Dosiou, C., Freeman, G., Lamont, C., Mauch, P., Nadler, L. M., & Griffin, J. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1126 · Cited by 150
Schneider, H., Martı́n, M., Agarraberes, F. A., Yin, L., Rapoport, I., Kirchhausen, T. L., & Rudd, C. E. (1999) · PubMed · Cited by 134
MOKYR, M. B., Kalinichenko, T. V., Gorelik, L., & Bluestone, J. A. (1998) · PubMed · Cited by 130
Chikuma, S., Imboden, J. B., & Bluestone, J. A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021646 · Cited by 129
Pistillo, M. P. (2002) · Blood · doi:10.1182/blood-2002-06-1668 · Cited by 127
Self-citationCTLA-4 regulates cell cycle progression during a primary immune response
Greenwald, R. J., Oosterwegel, M. A., van der Woude, D., Kubal, A., Mandelbrot, D. A., Boussiotis, V. A., & Sharpe, A. H. (2002) · European Journal of Immunology · Cited by 121
Fas-independent death of activated CD4 + T lymphocytes induced by CTLA-4 crosslinking
Scheipers, P., & Reiser, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10083 · Cited by 108
Nagaraju, K., Raben, N., Villalba, M. L., Danning, C. L., Loeffler, L., Lee, E. Y., Tresser, N. J., Abati, A. D., Fetsch, P. A., & Plötz, P. H. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4743 · Cited by 99
Expression of CTLA‐4 by Human Monocytes
Wang, X. ‐., Giscombe, R., Yan, Z., Heiden, T., Xu, D., & Lefvert, A. K. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.0300-9475.2001.01019.x · Cited by 90
Hamilton, N. H. R., Banyer, J., Hapel, A. J., Mahalingam, S., Ramsay, A. J., Ramshaw, I. A., & Thomson, S. A. (2002) · PubMed · Cited by 87
The CTLA-4 gene is expressed in placental fibroblasts
Kaufman, K. A. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.1.84 · Cited by 83
Costimulatory wars: the tumor menace
Hurwitz, A. A., Kwon, E. D., & van Elsas, A. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00147-3 · Cited by 74
Autoantibodies to T Cell Costimulatory Molecules in Systemic Autoimmune Diseases
Matsui, T., Kurokawa, M. S., Kobata, T., Oki, S., Azuma, M., Tohma, S., Inoue, T., Yamamoto, K., Nishioka, K., & Kato, T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4328 · Cited by 67
Self-citationNegative regulation of T cell activation
Saito, T. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80170-2 · Cited by 66
Hurwitz, A. A., Townsend, S. E., Yu, T. F.-Y., Wallin, J. A., & Allison, J. P. (1998) · International Journal of Cancer · Cited by 48
Tazzari, P. L., Polito, L., Bolognesi, A., Pistillo, M. P., Capanni, P., Palmisano, G. L., Lemoli, R. M., Curti, A., Biancone, L., Camussi, G., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4222 · Cited by 35
Self-citationAiroldi, I., Lualdi, S., Bruno, S., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600951 · Cited by 34
Villinger, F. J., Boštík, P., Mayne, A. E., King, C. L., Genain, C. P., Weiss, W. R., & Ansari, A. A. (2001) · Immunogenetics · doi:10.1007/s002510100322 · Cited by 32
Tsai, A. F., Kaufman, K. A., Walker, M. A., Karrison, T. G., Odem, R. R., Barnes, R. B., Scott, J. R., Schreiber, J. R., Stephenson, M. D., & Ober, C. (1998) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(98)00073-4 · Cited by 31
Martin‐Fontecha, A., Moro, M., Crosti, M., Veglia, F., Casorati, G., & Dellabona, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.698 · Cited by 24
Martelli, A. M., Cappellini, A., Tazzari, P. L., Billi, A. M., Tassi, C., Ricci, F., Falà, F., & Conte, R. (2004) · PubMed · Cited by 18
Self-citation(1997) · doi:10.1002/(sici)1097-4644(199702)64:2<295::aid-jcb12>3.0.co;2-i
Cited by
NK cells and cancer: you can teach innate cells new tricks
Morvan, M. G., & Lanier, L. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.5 · Cited by 1,162
Iwama, S., De Remigis, A., Callahan, M. K., Slovin, S. F., Wolchok, J. D., & Caturegli, P. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008002 · Cited by 715
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Gurbatri, C. R., Lia, I., Vincent, R., Coker, C., Castro, S., Treuting, P. M., Hinchliffe, T. E., Arpaia, N., & Danino, T. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax0876 · Cited by 647
Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
Gianferante, D. M., Mirabello, L., & Savage, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.16 · Cited by 477
Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights
Faje, A. (2016) · Pituitary · doi:10.1007/s11102-015-0671-4 · Cited by 326
Metadata
- Authors
- Contardi, E., Palmisano, G. L., Tazzari, P. L., Martelli, A. M., Falà, F., Fabbi, M., Kato, T., Lucarelli, E., Donati, D., Polito, L., Bolognesi, A., Ricci, F., Salvi, S., Gargaglione, V., Mantero, S., Alberghini, M., Ferrara, G. B., & Pistillo, M. P.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2005
- Volume
- 117
- Issue
- 4
- Pages
- 538-550
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1993851289
- Cited by
- 324
- References
- 47
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.